Angel Biotechnology Ltd Signs 450,000 stg Contract with Russia’s Materia

July 6, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said it has signed a contract worth about 450,000 stg with Russia-based Materia Medica Holdings for process development and GMP manufacture of polyclonal antibodies.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe